Investor Intelligence
Your portfolio’s next big idea. Each week, our analysts and leading Wall-Street experts provide in-depth analysis that dives deep on a company, opportunity or trend in markets. Brought to you by Finimize, the #1 financial information platform for modern investors.
Investor Intelligence
Harrow In Sharp Focus: This Fast-Growing Pharma Stock Just Got Cheaper
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Healthcare investing isn't always about blockbuster drugs – sometimes the best opportunities hide in profitable niches.
In this episode, we sit down with Finimize analyst Russell Burns to dig into Harrow, an ophthalmology pharma company whose stock has dropped 30% in recent weeks despite a still-strong growth outlook.
With shares up 400% over five years – dwarfing the S&P 500 – Russell explains why this pullback might be the entry point investors have been waiting for.
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
